(Q45872187)

17 December 2017

title

Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice (English)

1 reference

17 December 2017

1 reference

Petry H

1

1 reference

17 December 2017

Brooks A

2

1 reference

17 December 2017

Orme A

3

1 reference

17 December 2017

Wang P

4

1 reference

17 December 2017

Liu P

5

1 reference

17 December 2017

Xie J

6

1 reference

17 December 2017

Kretschmer P

7

1 reference

17 December 2017

Qian HS

8

1 reference

17 December 2017

Hermiston TW

9

1 reference

17 December 2017

Harkins RN

10

1 reference

17 December 2017

publication date

25 October 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

54-60

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303037

exact match

0 references

cites work

Clades of Adeno-associated viruses are widely disseminated in human tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

New recombinant serotypes of AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Treatment of human disease by adeno-associated viral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Immune responses to AAV in a phase I study for Canavan disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Additional transduction events after subretinal readministration of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Development and validation of a robust and versatile one-plasmid regulated gene expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303037

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3303037

1 reference

17 December 2017

Dimensions Publication ID

1006041190

0 references

1 reference

17 December 2017